Directory
>
Peter Jarrett
Peter Jarrett
Chief Scientific Officer | Ocular Therapeutix, Inc.
Waltham, Massachusetts, United States
Peter Jarrett
Summary
Peter Jarrett is a seasoned Chief Scientific Officer at Ocular Therapeutix, where he has been instrumental in advancing ocular drug delivery technologies since 2007. With a strong background in biomaterials and biomedical engineering, he has held various leadership roles in the pharmaceutical industry, including VP of Biomaterials R&D at Genzyme. Peter's expertise encompasses a wide range of areas such as drug delivery, polymer science, and quality systems, making him a key player in the development of innovative medical devices. His academic credentials include a Ph.D. in Polymer Science from the University of Connecticut, underscoring his deep understanding of materials that drive healthcare advancements. Throughout his career, he has been associated with both large corporations and smaller organizations, showcasing his adaptability and breadth of experience. Beyond his technical skills, Peter is passionate about the commercialization of scientific innovations and the intersection of technology and healthcare. He is committed to leading teams that push the boundaries of what's possible in medicine.
Peter Jarrett
Work Experience
Chief Scientific Officer at
Ocular Therapeutix, Inc.
July 2007 - Present
VP Biomaterials R&D at
Sanofi
July 2001 - July 2007
VP R&D at
Focal
January 1993 - January 2001
Assoc. Research Fellow at
Davis & Geck, Inc.
January 1989 - January 1993
Senior Chemist at
American Cyanamid
January 1984 - January 1989
Senior Chemist at
L3Harris
January 1982 - January 1984
Peter Jarrett
Education
University of Connecticut, Ph.D.
January 1978 - January 1983
Connecticut College, B.A.
January 1974 - January 1978
Frequently Asked Questions about Peter Jarrett
What is Peter Jarrett email address?
Peter Jarrett's primary email address is ********@ocutx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Peter Jarrett work for?
Peter Jarrett is a Chief Scientific Officer at Ocular Therapeutix, Inc., a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Peter Jarrett graduated from?
Peter Jarrett holds a degree in Polymer Science from University of Connecticut.
How can I directly contact Peter Jarrett?
To contact Peter Jarrett directly, you can use the email address ********@ocutx.com. Complete contact information is available upon registration with Muraena.
Who is Peter Jarrett?
Peter Jarrett is a seasoned Chief Scientific Officer at Ocular Therapeutix, where he has been instrumental in advancing ocular drug delivery technologies since 2007. With a strong background in biomaterials and biomedical engineering, he has held various leadership roles in the pharmaceutical industry, including VP of Biomaterials R&D at Genzyme. Peter's expertise encompasses a wide range of areas such as drug delivery, polymer science, and quality systems, making him a key player in the development of innovative medical devices. His academic credentials include a Ph.D. in Polymer Science from the University of Connecticut, underscoring his deep understanding of materials that drive healthcare advancements. Throughout his career, he has been associated with both large corporations and smaller organizations, showcasing his adaptability and breadth of experience. Beyond his technical skills, Peter is passionate about the commercialization of scientific innovations and the intersection of technology and healthcare. He is committed to leading teams that push the boundaries of what's possible in medicine.
Peter`s contact details
********@ocutx.com
Colleagues
Vice President Regulatory Affairs
Vice President, Market Access
Vice President, Head of Program Management
Executive Director, Marketing and Operations
Chief Operations Officer
Chief Financial Officer
Executive Director, Innovation & Strategic Collaborations
Member Board of Directors
Vice President, Deputy General Counsel, Chief Ethics and Compliance Officer
Vice President Clinical Development